Disclosure Of Interests In Other Entities [Text Block]

GenSight Biologics S.A. - Filing #2816652

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	53,363,000 EUR	—	—	—	43,759,000 EUR	—	—	—	—
Non-current assets	3,285,000 EUR	—	—	—	3,602,000 EUR	—	—	—	—
Current liabilities	22,242,000 EUR	—	—	—	17,123,000 EUR	—	—	—	—
Non-current liabilities	18,417,000 EUR	—	—	—	18,489,000 EUR	—	—	—	—
Revenue	—	—	5,276,000 EUR	—	—	4,394,000 EUR	—	—	—
Profit (loss)	—	28,617,000 EUR	28,617,000 EUR	—	—	34,015,000 EUR	—	34,015,000 EUR	—
Comprehensive income	—	28,617,000 EUR	28,824,000 EUR	207,000 EUR	—	33,684,000 EUR	331,000 EUR	34,015,000 EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	44,288,000 EUR	—	—	—	37,943,000 EUR	—	—	—	19,250,000 EUR
Tax expense (income)	—	—	2,000 EUR	—	—	2,000 EUR	—	—	—